However, tirzepatide is only available in the U.S
Combining GLP-1s with Menopausal Hormone Therapy (MHT): A Synergistic Approach Menopause weight loss is about addressing the metabolic shifts due to changing hormones
The results demonstrated that the 25mg daily pill delivered clinically meaningful weight loss: Average weight loss of 13.6-16.6% compared to 2.2-2.7% with placebo 76% of participants achieved at least 5% weight loss versus 31% on placebo Over 30% achieved 20% or greater weight loss Significant improvements in blood pressure, cholesterol, and inflammatory markers These results are comparable to what weve seen with injectable Wegovy, which typically produces 12-15% weight loss
Meet the Expert: Scott Kipnis, M.D., medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center
However, each option has unique features that may make one a better fit for your individual health needs
un chequeo clnico para saber en qu condiciones est la persona para determinar si puede o no utilizar esta medicacin
